Claims for Patent: 4,406,906

Summary for Patent: 4,406,906

Title:	Cerebral therapeutic agent and its use
Abstract:	The invention provides pharmaceutical compositions and medicaments, useful for the treatment of cerebral disorders, wherein the active compound is 1,4-dihydro-2,6-dimethyl-4-(3'-nitrophenyl)-pyridine-3-(.beta.-methoxyethy l ester)-5-(isopropyl ester). Also included in the invention are methods for the use of said compositions and medicaments.
Inventor(s):	Meyer; Horst (Wuppertal, DE), Bossert; Friedrich (Wuppertal, DE), Kazda; Stanislav (Wuppertal, DE), Hoffmeister; Friedrich (Wuppertal, DE), Vater; Wulf (Leverkusen, DE)
Assignee:	Bayer Aktiengesellschaft (Leverkusen, DE)
Application Number:	06/346,319
Patent Claims:	1. A method of combating pathologically reduced cerebral functions and performance weaknesses, cerebral insufficiency and disorders in cerebral circulation and metabolism in warm-blooded animals which comprises administering to the said animals a cerebral specific effective amount for treating said conditions of 1,4dihydro-2,6dimethyl-4-(3'-nitrophenyl)-pyridino-3-(.beta.-methoxyethyl ester)-5-isopropyl ester either alone or in admixture with a diluent or in the form of a medicament. 2. A method according to claim 1 in which the active compound is administered intravenously in an amount of 0.0001 to 0.5 mg per kg body weight per day, or enterally in an amount of 0.001 to 1 mg per kg body weight per day. 3. A method according to claim 1, in which the compound is administered intravenously in an amount of 0.001 to 0.1 mg per kg body weight per day, or enterally in an amount of 0.01 to 0.5 mg per kg body weight per day. 4. A method according to claim 1 or 2 in which the active compound is administered orally.